Acid Reflux Drugs Pose Higher Risk of Diabetes
Proton pump inhibitors (PPIs) have been extremely known as a treatment for acid reflux. However, a new study says that these medications can pose higher risks of developing type 2 diabetes.
“Owing to wide usage, the overall number of diabetes cases associated with PPI use could be considerable,” the researchers said. “For patients who have to receive long-term PPI treatment, screening for abnormal blood glucose, and type 2 diabetes is recommended.”
More About The Study
Upon analyzing more than 204,000 responses from participants, the researches found a connection between acid reflux drugs and a higher risk of type 2 diabetes.
After putting several factors that could increase the risk of type 2 diabetes — diet, exercise, and using other medications — the study determined that taking PPI regularly increased the risk of diagnosis by nearly 25 percent.
The researches revealed that participants could reduce the chance of developing diabetes by not consuming the medication. However, they also confirmed that the longer time consumers take drugs, the higher chance of suffering from diabetes.
Since these types of drugs have been widely used, it’s vital to let the consumers know about its risks. Furthermore, the research suggests that consumers who are using PPI as part of their medication to pay close attention to blood sugar levels.
Editor’s note on Acid Reflux Drugs Pose Higher Risk of Diabetes:
This piece is to inform you about the Frequent Use of Acid Reflux Drugs Poses a Higher Risk to Type 2 Diabetes.
For further information about this please don’t hesitate to send an email to Outreach@ConsiderTheConsumer.com, find us on Twitter or Facebook, or even connect with us directly on our website! We look forward to hearing from you all.
Similarly, please check out our current list of Class Actions and Class Action Investigations, here.
Interested in articles like these? Become a subscriber below!